Since the FDA officially approved the marketing of botulinum toxin A on June 5438+0989, botulinum toxin has been widely used in ophthalmology, neurology, rehabilitation and other fields. It is used to treat more than 30 dystonia diseases such as strabismus, eyelid spasm, hemifacial spasm, spastic torticollis, cerebral palsy in children, adult muscular spasm, etc., and is regarded as a major progress in neurology in the 1990s.

The anti-wrinkle effect of botulinum toxin A was discovered in 1986 by J.C., a professor of ophthalmology at the University of British Columbia School of Medicine in Vancouver, Canada. 1987, she and her husband, a professor of dermatology in our department, started the research on the anti-wrinkle effect of botulinum toxin A, and published the first research paper in 1992.

Since then, after achieving satisfactory results, especially after this method made Hollywood stars younger and more beautiful, botulinum toxin A has become popular in the beauty industry in the United States, with an annual growth rate of 1.42%, far behind other methods, and was predicted by authoritative experts as "the main method of beauty wrinkle removal in 2 1 century".